Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.68 +0.23 (9.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.45 | 52 Week High | $21.49 | |||
| Open | $2.48 | 52 Week Low | $15.75 | |||
| Day High | $2.70 | P/E | 3.05 | |||
| Day Low | $2.45 | EPS | $0.88 | |||
| Volume | 220,773 | |||||
